Polio vaccine study for adolescents and adults
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This trial tests a polio vaccine (sIPV) in healthy people aged 7-50 years. It aims to see how safe and effective the vaccine is, and may help protect against polio.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 7 and 50 years old and in good health.
- You can understand and sign a consent form (if you are 7-17, a parent or guardian must also sign).
- You agree to visit the clinic on schedule, get the vaccine, and provide samples as needed.
- If you or your partner can become pregnant, you must use effective birth control from signing up until 3 months after the last vaccine shot, and not plan to donate sperm or eggs.
- You do not have serious health problems like uncontrolled chronic illness, autoimmune disease, or bleeding disorders, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests giving babies two different types of polio vaccines in a specific order to see which is safer and more effective. If your baby is about 2 months old and hasn't had any polio vaccine yet, they may be able to join.
This trial tests new oral polio vaccines in healthy adults, children, and newborns. It aims to see if these vaccines are safe and help protect against polio.
This study tests a new oral polio vaccine given to healthy infants at 16 weeks old. It aims to see if the vaccine is safe and works well to protect against polio.
This trial tests a new oral polio vaccine in children and babies in Panama. The goal is to see if it is safe and helps the body build protection against polio.
This trial tests a new oral polio vaccine given to babies and young children. It aims to see whether the vaccine is safe and helps the body build protection against polio.
This study tests giving a new polio vaccine (nOPV2) right after birth to see how well it protects the gut. It is for healthy, full-term newborns whose parents agree to participate.
Hear when a new Poliomyelitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.